United States Tyrosine Kinase Inhibitor Market Growth Forecast 2034: Market Size, Share, and Future Opportunities
The United States is the largest contributor to North America's tyrosine kinase inhibitor market, driven by a high cancer burden and advanced oncology care infrastructure. Widespread biomarker testing and strong adoption of precision medicine help match patients with targeted therapies. A concentration of leading pharmaceutical companies and an active clinical trial landscape further support...
0 Commenti 0 condivisioni 212 Views 0 Anteprima